A detailed history of Jane Street Group, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 46,654 shares of BLFS stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,654
Previous 88,844 47.49%
Holding current value
$1.17 Million
Previous $1.9 Million 38.68%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.19 - $26.52 $809,626 - $1.12 Million
-42,190 Reduced 47.49%
46,654 $1.17 Million
Q2 2024

Aug 14, 2024

BUY
$15.14 - $22.99 $1.06 Million - $1.61 Million
69,921 Added 369.5%
88,844 $1.9 Million
Q1 2024

May 15, 2024

BUY
$15.35 - $18.82 $290,468 - $356,130
18,923 New
18,923 $351,000
Q2 2023

Aug 14, 2023

BUY
$17.19 - $24.34 $386,723 - $547,576
22,497 New
22,497 $497,000
Q2 2022

Aug 16, 2022

SELL
$10.54 - $24.2 $140,993 - $323,723
-13,377 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$20.81 - $37.29 $17,854 - $31,994
858 Added 6.85%
13,377 $304,000
Q4 2021

Feb 15, 2022

SELL
$32.99 - $58.55 $691,470 - $1.23 Million
-20,960 Reduced 62.61%
12,519 $467,000
Q3 2021

Nov 16, 2021

BUY
$42.03 - $60.5 $1.41 Million - $2.03 Million
33,479 New
33,479 $1.42 Million
Q2 2021

Aug 16, 2021

SELL
$29.51 - $44.62 $485,114 - $733,508
-16,439 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$32.95 - $44.24 $541,665 - $727,261
16,439 New
16,439 $592,000
Q4 2018

Feb 15, 2019

SELL
$9.5 - $17.17 $207,489 - $375,009
-21,841 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$14.99 - $25.48 $99,833 - $169,696
6,660 Added 43.87%
21,841 $382,000
Q2 2018

Aug 15, 2018

BUY
$6.18 - $13.49 $93,818 - $204,791
15,181 New
15,181 $173,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.07B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.